Blood Cancers
Insurers reject up to one-third of new specialty oral blood cancer prescriptions
SAN DIEGO — Insurers rejected one-third of new prescriptions for specialty oral anticancer medications ordered for patients with blood cancers, according to retrospective data presented at ASH Annual Meeting and Exposition. Patients with commercial insurance and Medicaid had prescriptions rejected more often than patients with Medicare.
Blood test may predict response to CAR T-cell therapy in relapsed multiple myeloma
A simple blood test that measures lymphocyte count may accurately predict response to chimeric antigen receptor T-cell therapy among patients with relapsed multiple myeloma, according to study results.
VIDEO: No association between point mutations and blood cancer precursors
In this video, Rosalie Griffin, PhD, discusses the results of a study into point mutations and their correlation with developing blood cancers presented at ESMO Congress 2024.
Dana-Farber president announces intention to step down, successor named
Laurie H. Glimcher, MD, announced her intention to step down as president and CEO of Dana-Farber Cancer Institute on Oct. 1.
VIDEO: Approaching treatment in myeloproliferative neoplasms varies by patient
In this video, Tania Jain, MBBS, director of the Immune Effector Cell Therapy Program and associate professor of oncology at Johns Hopkins University, discussed the different approaches to treating different types of MPNs, like myelofibrosis, essential thrombocythemia and polycythemia vera.
Those with blood cancers ‘can’t rely on vaccination’ for protection from severe COVID-19
Regardless of vaccination status, individuals with hematologic malignancies had increased odds of developing severe COVID-19 until oral antivirals became widely available in mid-2022, according to data published in JAMA Network Open.
AI tool addresses ‘clinical conundrum’ by accurately identifying rare blood cancers
SAN DIEGO — An international group of researchers developed an artificial intelligence-based algorithm that differentiates prefibrotic primary myelofibrosis from essential thrombocythemia during pathological analysis, study findings showed.
What is hematology?
Hematology is the science or study of blood and blood diseases.
Social determinants of health linked to poorer survival among people with blood cancers
Several factors contributed to inequities of outcomes among people with hematologic malignancies in the United States, according to findings presented at Society of Hematologic Oncology Annual Meeting.
Intervention reduces financial toxicity among people with blood cancers
An oncology financial navigation intervention decreased financial toxicity among patients with blood cancers and their caregivers, according to study results.